• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Pre-activation timing determines influenza severity and viral pathogenicity via STING Inhibition

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Dec 24;15(1):44501.
doi: 10.1038/s41598-025-28063-w. Pre-activation timing determines influenza severity and viral pathogenicity via STING Inhibition

Tong Zhu[SUP] 1 [/SUP], Mengru Zhu[SUP] 1 [/SUP], Feiyu Lu[SUP] 2 [/SUP], Kuo Qu[SUP] 3 [/SUP], Hong Wang[SUP] 2 [/SUP], Shengnan Wang[SUP] 2 [/SUP], Zhengyi Sun[SUP] 4 [/SUP], Yongli Yu[SUP] 3 [/SUP], Liying Wang[SUP] 5 [/SUP], Chaoying Yan[SUP] 6 [/SUP]



Affiliations
Abstract

Severe influenza is frequently associated with bacterial or viral co-infections. Although immune-mediated mechanisms have been extensively investigated, the cell-intrinsic responses of respiratory epithelial cells prior to immune engagement remain poorly characterized. To model co-infection in vitro, we pre-activated B16 melanoma cells using the TLR9 agonist CpG ODN, followed by infection with influenza A virus (IAV) strain FM1. Key molecular events, including STING expression and activation, were assessed by Western blotting and RT-qPCR. The in vivo relevance was assessed in a mouse model of intranasal CpG ODN pre-treatment and IAV challenge. RNA-seq was performed as a supplementary approach to explore possible cell death pathways. Pre-activation significantly enhanced IAV-induced cell death within a restricted vulnerability window (≤ 24 h), independent of viral replication or TLR9 signaling. This was associated with inflammatory priming and initial STING activation. However, IAV infection subsequently suppressed STING phosphorylation and elevated inflammatory cell death. Mice pre-treated with CpG ODN exhibited increased mortality and aggravated lung injury following IAV challenge. RNA-seq analysis suggested the potential involvement of pyroptosis. These findings demonstrate that cellular pre-stimulation exacerbates influenza severity by promoting inflammatory cell death, a process mechanistically linked to the subsequent suppression of STING activation. This study reveals a novel pathogenic cell-intrinsic mechanism in co-infection pathogenesis.

Keywords: Cell death; Infection; Influenza virus; Pre-activation; STING.

 
Back
Top